Acute myocardial infarction (AMI) is a major cause of morbidity and mortality worldwide.
Timely reperfusion with primary percutaneous coronary intervention (PPCI) remains the gold …

Introduction Inflammation plays a critical role in the pathogenesis of atherosclerosis, the
leading cause of ischaemic heart disease (IHD). Studies in preclinical models have …

Abstract Aims Acute coronary syndromes (ACSs) are driven by inflammation within coronary
plaque. Interleukin-1 (IL-1) has an established role in atherogenesis and the vessel …

Background The prognostic value of interleukin (IL)-10 in patients with ST-segment
elevation acute myocardial infarction (ST-se AMI) is currently unclear. The purpose of this …

Since it has been elucidated that myocardial reperfusion can reduce myocardial infarct size
following an acute coronary artery occlusion, nowadays, myocardial reperfusion therapy …

ST-segment elevation myocardial infarction (STEMI) is a major cause of mortality and
disability worldwide. Reperfusion therapy by thrombolysis or primary percutaneous coronary …

Background: The inflammatory response of the immune system plays a major role in the
period following an acute myocardial infarction (MI), as it coordinates the formation of the …

Many cytokines are currently under investigation as potential target to improve cardiac
function and outcome in the setting of acute myocardial infarction (MI) or chronic heart failure …

In patients with an acute ST-segment elevation myocardial infarction, timely myocardial
reperfusion using primary percutaneous coronary intervention is the most effective therapy …

Ørn S, Ueland T, Manhenke C, Sandanger Ø, Godang K, Yndestad A, Mollnes TE, Dickstein
K, Aukrust P (Stavanger University Hospital, Stavanger; Oslo University Hospital …